Results 91 to 100 of about 272,494 (175)

TaqI polymorphism in the human LDL receptor gene [PDF]

, 1987
Kimiko Yamakawa, Takaaki Okafuji, Yukio Iwamura, David W. Russell, Hideo Hamaguchi   +4 more
openalex   +1 more source

Comparison of LDL- Cholesterol Enzymatic Method with Friedewald’s Formula

Medical Laboratory Journal, 2015
Background and Objectives: Concentration low-density lipoprotein (LDL) is one of the strongest indicators of atherosclerosis and predicts the diagnosis of cardiovascular diseases. LDL measurement accuracy is very important.
Hamidreza Yazdi, Fatemeh Piran, Sanaz Royani, Mojgan Nejabat, Gholamreza Roshandel, Mahsa Taherizadeh, Hamid Reza Joshaghani   +6 more
doaj  

A novel explanation for the reduced LDL cholesterol in severe hypertriglyceridemia.

, 1989
Anne Minnich, Børge G. Nordestgaard, D.B. Zilversmit   +2 more
openalex   +1 more source

A new micromethod for routine measurement of serum LDL-apolipoprotein B.

, 1988
G. E. ANDERSEN, Hanne Gry, Gerhard M. Kostner   +2 more
openalex   +1 more source

Detection and quantitation of low density lipoprotein (LDL) receptors in human liver by ligand blotting, immunoblotting, and radioimmunoassay. LDL receptor protein content is correlated with plasma LDL cholesterol concentration.

, 1986
Anne K. Soutar, K. Harders-Spengel, David P. Wade, Brian L. Knight   +3 more
openalex   +1 more source

Ceruloplasmin and oxidized LDL colocalize in atherosclerotic lesions of hamster

Open Life Sciences, 2011
Stancu Camelia, Constantinescu Elena, Sima Anca   +2 more
doaj   +1 more source

Low-Density Lipoprotein Cholesterol Increases Significantly During Brief Discontinuation of Atorvastatin and Correlates With Metabolite Half-Lives. [PDF]

Pharmacol Res Perspect
Pivoriunas J, Vethe NT, Kristiansen O, Bergan S, Husebye E, Munkhaugen J, Sverre E.   +6 more
europepmc   +1 more source

Effects of γ-oryzanol on the Serum HDL, LDL cholesterol in the Aged

, 1981
Tsutomu Iwasaki, Satoru Matsushita, Hajime Orimo, Masataka Shiraki, Nobutó Moroki, Yoichi Kato, Ryutaro Takahashi, Kizuku Kuramoto, Mototaka Murakami, Akio Noma, Hiroaki Okabe   +10 more
openalex   +2 more sources

The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention. [PDF]

Curr Atheroscler Rep
Kamanu C, Karalis DG.
europepmc   +1 more source

Stoichiometric Binding of Low Density Lipoprotein (LDL) and Monoclonal Antibodies to Ldl Receptors in a Solid Phase Assay

, 1989
Ian R. van Driel, Mark S. Brown, J L Goldstein   +2 more
openalex   +1 more source